Whitening of brown adipose tissue inhibits osteogenic differentiation via secretion of S100A8/A9
© 2024 The Authors..
The mechanism by which brown adipose tissue (BAT) regulates bone metabolism is unclear. Here, we reveal that BAT secretes S100A8/A9, a previously unidentified BAT adipokine (batokine), to impair bone formation. Brown adipocytes-specific knockout of Rheb (RhebBAD KO), the upstream activator of mTOR, causes BAT malfunction to inhibit osteogenesis. Rheb depletion induces NF-κB dependent S100A8/A9 secretion from brown adipocytes, but not from macrophages. In wild-type mice, age-related Rheb downregulation in BAT is associated with enhanced S100A8/A9 secretion. Either batokines from RhebBAD KO mice, or recombinant S100A8/A9, inhibits osteoblast differentiation of mesenchymal stem cells in vitro by targeting toll-like receptor 4 on their surfaces. Conversely, S100A8/A9 neutralization not only rescues the osteogenesis repressed in the RhebBAD KO mice, but also alleviates age-related osteoporosis in wild-type mice. Collectively, our data revealed an unexpected BAT-bone crosstalk driven by Rheb-S100A8/A9, uncovering S100A8/A9 as a promising target for the treatment, and potentially, prevention of osteoporosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
iScience - 27(2024), 2 vom: 16. Feb., Seite 108857 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Ting [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 03.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.isci.2024.108857 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367930714 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367930714 | ||
003 | DE-627 | ||
005 | 20240203232018.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240202s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.isci.2024.108857 |2 doi | |
028 | 5 | 2 | |a pubmed24n1279.xml |
035 | |a (DE-627)NLM367930714 | ||
035 | |a (NLM)38303710 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Ting |e verfasserin |4 aut | |
245 | 1 | 0 | |a Whitening of brown adipose tissue inhibits osteogenic differentiation via secretion of S100A8/A9 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 03.02.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2024 The Authors. | ||
520 | |a The mechanism by which brown adipose tissue (BAT) regulates bone metabolism is unclear. Here, we reveal that BAT secretes S100A8/A9, a previously unidentified BAT adipokine (batokine), to impair bone formation. Brown adipocytes-specific knockout of Rheb (RhebBAD KO), the upstream activator of mTOR, causes BAT malfunction to inhibit osteogenesis. Rheb depletion induces NF-κB dependent S100A8/A9 secretion from brown adipocytes, but not from macrophages. In wild-type mice, age-related Rheb downregulation in BAT is associated with enhanced S100A8/A9 secretion. Either batokines from RhebBAD KO mice, or recombinant S100A8/A9, inhibits osteoblast differentiation of mesenchymal stem cells in vitro by targeting toll-like receptor 4 on their surfaces. Conversely, S100A8/A9 neutralization not only rescues the osteogenesis repressed in the RhebBAD KO mice, but also alleviates age-related osteoporosis in wild-type mice. Collectively, our data revealed an unexpected BAT-bone crosstalk driven by Rheb-S100A8/A9, uncovering S100A8/A9 as a promising target for the treatment, and potentially, prevention of osteoporosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cell biology | |
650 | 4 | |a Molecular biology | |
650 | 4 | |a Physiology | |
700 | 1 | |a Zhao, Chaoran |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jiahuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Shengfa |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Youming |e verfasserin |4 aut | |
700 | 1 | |a Gong, Yan |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Yingyue |e verfasserin |4 aut | |
700 | 1 | |a Yan, Lei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Sheng |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Zhongmin |e verfasserin |4 aut | |
700 | 1 | |a Hu, Hongling |e verfasserin |4 aut | |
700 | 1 | |a Liu, Anling |e verfasserin |4 aut | |
700 | 1 | |a Bai, Xiaochun |e verfasserin |4 aut | |
700 | 1 | |a Zou, Zhipeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t iScience |d 2018 |g 27(2024), 2 vom: 16. Feb., Seite 108857 |w (DE-627)NLM285332627 |x 2589-0042 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2024 |g number:2 |g day:16 |g month:02 |g pages:108857 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.isci.2024.108857 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2024 |e 2 |b 16 |c 02 |h 108857 |